hyetellose + sodium chloride: prescribing and clinical use
Focused clinical detail for use alongside current product information, local policy and patient-specific assessment.
hyetellose + sodium chloride: clinical details
Prescribing considerations
- Confirm symptoms are consistent with dry eye related to deficient tear secretion; assess persistent, unilateral or red-flag symptoms.
- Warn about transient stinging or blurred vision and advise waiting until vision is clear before driving.
- Stop treatment and reassess if irritation worsens, persists or is accompanied by continuing redness.
- No routine laboratory monitoring is specified.
Contraindications and cautions
- Hypersensitivity to hyetellose, sodium chloride, borax, boric acid or another formulation component.
Monitoring
- Clinical response and ocular comfort
- Persistent irritation or redness
- New pain, photophobia or visual change
Clinical pharmacology
Hyetellose provides viscolising and lubricating effects. With sodium chloride, it acts as an artificial tear and has increased tear-film break-up time in animal models. Conventional systemic pharmacokinetic assessment is not applicable.
Formulation and product differences
- Clear, colourless sterile ophthalmic solution.
- Preservative-free single-use units.
- Excipients include purified water, borax and boric acid.
- Discard each unit after one use; protect from light and freezing.
hyetellose + sodium chloride interactions
No interactions with other medicines are known for this product.
Sources
These sources were used to prepare and review this medicine page.
Prepared and reviewed by the iatroX editorial team.